Monday, November 19, 2012    |    eCliniqua.com    |    Archives    |   Advertising   |    CHI Conferences    |     Subscribe       

 

FEATURED ARTICLES 

Janssen Launches Shared Investigator Database
eCliniqua | As part of the newly-launched TransCelerate BioPharma, Janssen Research & Development has established a global cross-pharma Investigator Databank designed to improve efficiencies of industry-sponsored clinical trials. Merck and Eli Lilly and Company are the first two companies to join Janssen in this effort. Read More 

Site Solutions Summit 2012: New Trade Association Grabs Spotlight
eCliniqua | The recently held annual Site Solutions Summit* was a high energy gathering of 500 clinical trial professionals culminating with a big announcement—the formation of the Society for Clinical Research Sites (SCRS). This new trade association is intended to provide a much-needed collective voice and a community for global investigative sites, which are anxious for a place at the table as the clinical trials industry works to improve operational efficiency. Read More 

ELSEWHERE IN THE NEWS 

Site Management Organizations Combine
News Brief | The parent company for Clinical Research Advantage has acquired Radiant Research. By combining these two site management organizations, the group now has 57 sites with more than 550 research professionals and an aggressive plan for growth. Read More 

Trials Collecting Unncessary Data, Wasting Money
Pharmalot | Unnecessary trial endpoints are a waste of clinical trials budget, finds a study released by the Tufts Center for the Study of Drug Development. Read More 

Health Canada to Launch Trial Listing
Macleans | Canada lags behind in clinical trials transparency, but Health Canada has plans for an online trial listing, similar to the US ClinicalTrials.gov. Read More 

Updated EDC for Any Research Initiative
Product Brief | The latest version of iMedNet EDC was announced today. iMedNet EDC makes electronic data capture functionality practical for any type of research initiative, even very small studies of short duration. Read More 

Clinical Trials Influencing Investors
Seeking Alpha | Do clinical trial results sway biotech investors? Investors may be able to determine FDA approvals from trials, but then again they may not. Read More 

BioClinica Expands Imaging Services
News Brief |  BioClinica has announced the immediate availability of new and expanded imaging services critical for clinical trials in the area of osteoarthritis. Read More